Helpful Bacterial Metabolites

While gut microbiota appear to have both positive and negative impacts on our  health, in the guts of healthy, lean individuals, the good outweighs the bad.  

By | August 1, 2011

Infographic: Helpful Bacterial Metabolites
View full size JPG | PDF
ANDREW SWIFT

While gut microbiota appear to have both positive and negative impacts on our  health, in the guts of healthy, lean individuals, the good outweighs the bad.  Gut  bacteria, most of which reside in the large intestine, process many otherwise  indigestible components of foods, converting them into an estimated 10 percent of our daily energy supply.  But in addition to eking out additional nutrients from our food, gut bacteria also produce a number of metabolic by-products that improve our immune systems, strengthen the lining of the gut—our best barrier to infection—and confer anticancer benefits.

 

Read the full story.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Iwona Grad

Anonymous

August 31, 2011

Well, this is nothing new and surprising. Just look at the effective microorganisms of dr Teruo Higa

Avatar of:

Posts: 0

August 31, 2011

Well, this is nothing new and surprising. Just look at the effective microorganisms of dr Teruo Higa

Avatar of:

Posts: 0

August 31, 2011

Well, this is nothing new and surprising. Just look at the effective microorganisms of dr Teruo Higa

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech